Literature DB >> 16971391

The SHB adapter protein is required for normal maturation of mesoderm during in vitro differentiation of embryonic stem cells.

Vitezslav Kriz1, Nina Agren, Cecilia K Lindholm, Samuel Lenell, Johan Saldeen, Jaroslav Mares, Michael Welsh.   

Abstract

Definitive mesoderm arises from a bipotent mesendodermal population, and to study processes controlling its development at this stage, embryonic stem (ES) cells can be employed. SHB (Src homology 2 protein in beta-cells) is an adapter protein previously found to be involved in ES cell differentiation to mesoderm. To further study the role of SHB in this context, we have established ES cell lines deficient for one (SHB+/-) or both SHB alleles (SHB-/-). Differentiating embryoid bodies (EBs) derived from these ES cell lines were used for gene expression analysis. Alternatively, EBs were stained for the blood vessel marker CD31. For hematopoietic differentiation, EBs were differentiated in methylcellulose. SHB-/- EBs exhibited delayed down-regulation of the early mesodermal marker Brachyury. Later mesodermal markers relatively specific for the hematopoietic, vascular, and cardiac lineages were expressed at lower levels on day 6 or 8 of differentiation in EBs lacking SHB. The expression of vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1 was also reduced in SHB-/- EBs. SHB-/- EBs demonstrated impaired blood vessel formation after vascular endothelial growth factor stimulation. In addition, the SHB-/- ES cells formed fewer blood cell colonies than SHB+/+ ES cells. It is concluded that SHB is required for appropriate hematopoietic and vascular differentiation and that delayed down-regulation of Brachyury expression may play a role in this context.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16971391     DOI: 10.1074/jbc.M604084200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  The Shb scaffold binds the Nck adaptor protein, p120 RasGAP, and Chimaerins and thereby facilitates heterotypic cell segregation by the receptor EphB2.

Authors:  Melany J Wagner; Marilyn S Hsiung; Gerald D Gish; Rick D Bagshaw; Sasha A Doodnauth; Mohamed A Soliman; Claus Jørgensen; Monika Tucholska; Robert Rottapel
Journal:  J Biol Chem       Date:  2020-02-14       Impact factor: 5.157

2.  The Src homology 2 domain-containing adapter protein B (SHB) regulates mouse oocyte maturation.

Authors:  Gabriela Calounova; Gabriel Livera; Xiao-Qun Zhang; Kui Liu; Roger G Gosden; Michael Welsh
Journal:  PLoS One       Date:  2010-06-16       Impact factor: 3.240

Review 3.  Vascular endothelial growth factor A: just one of multiple mechanisms for sex-specific vascular development within the testis?

Authors:  Kevin M Sargent; Renee M McFee; Renata Spuri Gomes; Andrea S Cupp
Journal:  J Endocrinol       Date:  2015-10-15       Impact factor: 4.286

Review 4.  VEGF receptor signaling in vertebrate development.

Authors:  Joaquim Miguel Vieira; Christiana Ruhrberg; Quenten Schwarz
Journal:  Organogenesis       Date:  2010 Apr-Jun       Impact factor: 2.500

5.  The Src homology-2 protein Shb modulates focal adhesion kinase signaling in a BCR-ABL myeloproliferative disorder causing accelerated progression of disease.

Authors:  Karin Gustafsson; Maria Jamalpour; Camilla Trinh; Michael G Kharas; Michael Welsh
Journal:  J Hematol Oncol       Date:  2014-06-21       Impact factor: 17.388

6.  SmShb, the SH2-Containing Adaptor Protein B of Schistosoma mansoni Regulates Venus Kinase Receptor Signaling Pathways.

Authors:  Marion Morel; Mathieu Vanderstraete; Katia Cailliau; Steffen Hahnel; Christoph G Grevelding; Colette Dissous
Journal:  PLoS One       Date:  2016-09-16       Impact factor: 3.240

7.  Pro-tumoral immune cell alterations in wild type and Shb-deficient mice in response to 4T1 breast carcinomas.

Authors:  Xiujuan Li; Kailash Singh; Zhengkang Luo; Mariela Mejia-Cordova; Maria Jamalpour; Björn Lindahl; Ganlin Zhang; Stellan Sandler; Michael Welsh
Journal:  Oncotarget       Date:  2018-04-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.